![Foto de GUILLERMO](/img/uploaded/AE2E4883EE273F23E7425D3456C338A2.jpg)
GUILLERMO
QUINDOS ANDRES
PROFESORADO CATEDRATICO/A DE UNIVERSIDAD
Publicaciones (284) Publicaciones de GUILLERMO QUINDOS ANDRES
2024
-
Efficacy of the combination of amphotericin B and echinocandins against Candida auris in vitro and in the Caenorhabditis elegans host model
Microbiology spectrum, Vol. 12, Núm. 1, pp. e0208623
2023
-
Assessing pH-dependent activities of virulence factors secreted by Candida albicans
MicrobiologyOpen, Vol. 12, Núm. 1
-
In Vitro and In Vivo Activity of Citral in Combination with Amphotericin B, Anidulafungin and Fluconazole against Candida auris Isolates
Journal of Fungi, Vol. 9, Núm. 6
-
PK/PD modeling and simulation of the in vitro activity of the combinations of isavuconazole with echinocandins against Candida auris
CPT: Pharmacometrics and Systems Pharmacology, Vol. 12, Núm. 6, pp. 770-782
-
Presence and implication of Candida spp. in patients with peri-implantitis enrolled in a supportive peri-implant therapy program of the Basque Country (Spain). A case–control study
Clinical Implant Dentistry and Related Research, Vol. 25, Núm. 5, pp. 938-947
2022
-
In vitro and in vivo anti-Candida activity of citral in combination with fluconazole
Journal of Oral Microbiology, Vol. 14, Núm. 1
-
Antimicrobial Peptides with Anti-Candida Activity
International Journal of Molecular Sciences, Vol. 23, Núm. 16
-
Impact of Aspergillus spp. isolation in the first 24 hours of admission in critically ill patients with severe influenza virus pneumonia
Medicina Intensiva
-
Impact of Aspergillus spp. isolation in the first 24 hours of admission in critically ill patients with severe influenza virus pneumonia
Medicina intensiva, Vol. 46, Núm. 8, pp. 426-435
-
In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study
Frontiers in Cellular and Infection Microbiology, Vol. 12
-
Postantifungal Effect of Antifungal Drugs against Candida: What Do We Know and How Can We Apply This Knowledge in the Clinical Setting?
Journal of Fungi, Vol. 8, Núm. 7
2021
-
Candida parapsilosis colony morphotype forecasts biofilm formation of clinical isolates
Journal of Fungi, Vol. 7, Núm. 1, pp. 1-12
-
Candidiasis by candida glabrata, candida nivariensis and candida bracarensis in galleria mellonella: Virulence and therapeutic responses to echinocandins
Journal of Fungi, Vol. 7, Núm. 12
-
Development and characterization of monoolein-based liposomes of carvacrol, cinnamaldehyde, citral, or thymol with anti-candida activities
Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 4
-
Erratum: Development and characterization of monoolein-based liposomes of carvacrol, cinnamaldehyde, citral, or thymol with Anti-Candida activities (Antimicrobial Agents and Chemotherapy (2021) 65:4 (e01628-20) DOI: 10.1128/AAC.01628-20)
Antimicrobial Agents and Chemotherapy
-
In vitro activities of carvacrol, cinnamaldehyde and thymol against Candida biofilms
Biomedicine and Pharmacotherapy, Vol. 143
-
In vitro interaction and killing-kinetics of amphotericin b combined with anidulafungin or caspofungin against candida auris
Pharmaceutics, Vol. 13, Núm. 9
-
In vitro pharmacokinetic/pharmacodynamic modelling and simulation of amphotericin b against candida auris
Pharmaceutics, Vol. 13, Núm. 11
-
In vitro synergistic interactions of isavuconazole and echinocandins against Candida auris
Antibiotics, Vol. 10, Núm. 4
-
Liposomal amphotericin B: thirty years of a highly effective therapy for the treatment of invasive mycoses
Revista Iberoamericana de Micologia, Vol. 38, Núm. 2, pp. 39-41